- Daaweyn
- Markhaatiyada
- Neuroblastoma
- Buro adag
- Markhaatiyada
- TILS
- Daaweynta Unugyada NK
- Myasthenia Gravis (MG)
- Leukemia-da Lymphoblastic ee Ba'an (B-ALL)
- Lupus Erythematosus oo nidaamsan (SLE)
- Leukemia-da Lymphoblastic ee Ba'an (T-ALL)
- Lymphoma-ka aan Hodgkin ahayn (NHL)
- Myeloma badan (MM)
- Lymphom-ka Unugga B-B ee Kala-baxa
- Leukemia-da B-lymphocytic
- Myeloma
Mudane D----CanadianBaadhista: Limfooma-ka Unugga B-unugga ee Diffuse Large (DLBCL) oo leh isbeddel TP53 ah
Annaga oo ah hay'ad caafimaad, waxaan fursad u helnay inaan daweyno bukaan lagu magacaabo Mr. D, oo ka soo jeeda Kanada. Waxaa laga helay cudurka Diffuse Large B-cell Lymphoma (DLBCL) oo lagu sameeyay isbeddel TP53 ah, xaalad caqabado waaweyn ku ah hababka daaweynta dhaqameed.
Mudane D wuxuu bilaabay safarkiisa si uu ula dagaallamo cudurkan halista ah isagoo leh rajo iyo go'aan qaadasho astaan u ah shakhsiyaddiisa. Markii hore, wuxuu maray kiimoterabi-ka-horreedka R-CHOP, oo ah hab-raac daaweyn caadi ah oo loogu talagalay DLBCL. Iyadoo ay jiraan rajadii ugu horreysay, isku daygii xigay ee daaweynta safka labaad sida R-DHAP iyo GEMOX-BTKi waxay noqdeen kuwo aan waxba tarayn, taasoo xaaladdiisa ka dhigtay mid aan degganayn, taasoo niyad jab ku keentay Mudane D iyo kooxdiisa caafimaadka labadaba.
Annagoo aqoonsanay degdegga xaaladda iyo baahida loo qabo xalal cusub, waxaan go'aansannay inaan Mr. D ku darno qorshaha daaweynta CD19-CAR-T. Habkan casriga ah ee daaweynta kansarka wuxuu ka faa'iidaysanayaa awoodda habdhiska difaaca jirka si uu u bartilmaameedsado una burburiyo unugyada kansarka, isagoo rajo siinaya bukaanada sida Mr. D oo daalay fursadaha daaweynta caadiga ah.
Natiijooyinku waxay ahaayeen kuwo cajiib ah. Hal bil ka dib markii la geliyay unugyada CD19-CAR-T, Mr. D wuxuu gaaray cafis dhammaystiran, taasoo u muuqatay mid aan la gaari karin toddobaadyo ka hor. Si kastaba ha ahaatee, safarkan cafis ma ahayn mid aan lahayn caqabado. Mr. D wuxuu la kulmay cudurka sii deynta cytokine-ka heerka dhexe (CRS) iyo cudurka neurotoxicity-ga ee la xiriira unugyada saamaynta difaaca jirka ee heerka 1 (ICANS) inta lagu jiro daaweynta. Nasiib wanaag, kooxdayada caafimaadka ee feejigan ayaa si degdeg ah u soo faragelisay, iyagoo si wax ku ool ah u maareeyay dhibaatooyinkan iyagoo adeegsanaya tocilizumab, adalimumab, iyo daaweynta hoormoonka, iyagoo hubinaya badbaadada iyo raaxada Mr. D inta lagu jiro hawsha.
Waxtarka daaweynta unugyada CAR-T ee kiiska Mr. D wuxuu u adeegaa calaamad rajo u ah bukaanada DLBCL ee aan awoodin inay ka gudbaan adduunka oo dhan, taasoo muujinaysa awoodda isbeddelka ee qaabkan daaweynta ee hal-abuurka leh. Intaa waxaa dheer, safarka Mr. D wuxuu iftiiminayaa doorka lama huraanka ah ee shaqada kooxeed ee kala duwan iyo daryeelka naxariista leh ee dagaalka ka dhanka ah kansarka.
Isagoo ka tarjumaya waayo-aragnimadiisa, Mr. D wuxuu aad uga mahadceliyay taageerada aan kala go 'lahayn iyo khibradda kooxdiisa caafimaadka. "Heerka daryeelka iyo dadaalka aan helay intii aan daweynayay ma ahayn mid aan la barbar dhigi karin," ayuu yiri. "Ma aha oo kaliya inay daweeyeen cudurkayga, laakiin sidoo kale waxay daweeyeen baahiyahayga shucuureed iyo nafaqada, iyagoo hubinaya inaan dareemay taageero tallaabo kasta oo jidka ah."
Sheekada Mr. D waxay markhaati u tahay adkeysiga ruuxa aadanaha iyo horumarka la yaabka leh ee laga sameeyay cilmiga kansarka. Annagoo sii wadna inaan xoojinno xuduudaha hal-abuurka caafimaadka, waxaan weli ka go'an nahay inaan daryeel shaqsiyeed oo naxariis leh siino bukaan kasta oo naga aamina caafimaadkooda iyo fayoobaantooda.

Bilowga cudurka & maalin ka hor & bil ka dib tallaalka.
sharraxaad2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

